The Neurology Lounge started in July 2015 and it is now well into its 2nd year. 2016 was the first complete 12-month calendar period, and during this time the blog received about 25,000 visits and just under 40,000 views. There were visitors from >150 countries around the world with the United States recording the most visits at… Read More What were the most popular posts on The Neurology Lounge in 2016?
Opicapone as an adjunct to levodopa in patients with Parkinson’s disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial Ferreira JJ, Lees A, Rocha JF, et al; Bi-Park 1 investigators. Lancet Neurol 2016; 15:154-165 Abstract BACKGROUND: Opicapone is a novel, once-daily, potent third-generation catechol-O-methyltransferase inhibitor. We aimed to assess the safety and efficacy of […]… Read More What are the emerging drug treatments for Parkinson’s disease (1)
Neurochecklists is in a continuous process of improvement and enhancement. To do so, it keeps up with the latest neurology articles and reviews, and stays on top of the latest guidelines and current trends. And these are churned out by the minute. In the Neurochecklists spirit of comprehensiveness and recency, below are 10 recent checklists… Read More 10 revised and refreshed neurochecklists
Medical futurists predict that scientific advances will lead to more precise definition of diseases. This will inevitably result in the emergence of more diseases and fewer syndromes. This case is made very eloquently in the book, The Innovators Prescription. Many neurological disorders currently wallow at the intuitive end of medical practice, and their journey towards precision medicine is painfully too slow. Neurology therefore… Read More What are the new diseases emerging in neurology?
Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis Nikolic AV, Bojic SD, Rakocevic Stojanovic VM, Basta IZ, Lavrnic DV Eur J Neurol 2016; 23:1635-1641. Abstract BACKGROUND AND PURPOSE: The aim was to determine the electrophysiological profile of our cohort of low density lipoprotein receptor related protein 4 (LRP4)… Read More What does the EMG show in LRP4 myasthenia gravis?
Sildenafil in the Treatment of Erectile Dysfunction in Parkinson’s Disease Bernard BA, Metman LV, Levine L, et al. Mov Disord Clin Pract 2016; DOI: 10.1002/mdc3.12456 (Epub ahead of issue) Abstract Background Erectile dysfunction (ED) is a common non-motor feature in patients with Parkinson’s disease (PD). Data regarding the tolerability and efficacy of anti-ED medication in… Read More Is sildenafil safe and effective for erectile dysfunction in Parkinson’s disease? — Neurochecklists Updates
Abnormal glucose regulation increases stroke risk in minor ischemic stroke or TIA Pan Y, Jing J, Li H, Wang Y, Wang Y, He Y; CHANCE investigators. Neurology 2016; 87:1551-1556. Abstract OBJECTIVE: To investigate whether abnormal glucose regulation contributes to a new stroke in patients with a minor ischemic stroke or TIA. METHODS: We derived data… Read More Does impaired glucose tolerance increase the risk of stroke recurrence? — Neurochecklists Updates